PRRT Officially Launched in New Zealand
On July 14, New Zealand patients celebrated a great leap forward in NET cancer care. The New Zealand Government announced the launch of Peptide Receptor Radionuclide Therapy (PRRT) as a national cancer treatment. The service will be based in the largest city –...
Unicorn Foundation New Zealand Welcomes New CEO
Unicorn Foundation NZ’s board and staff recently introduced Dr. Michelle Sullivan as the organization’s new CEO. Dr. Michelle Sullivan’s wealth of experience aligns well with the strategic goals of Unicorn Foundation NZ and the team is excited about what her...
NET Education Day Talks by Unicorn Foundation New Zealand Available Online
The Unicorn Foundation New Zealand recently published videos of some of the NET specialist talks delivered on NET Education Day in New Zealand on their YouTube channel. The topics covered are as follows: • Imaging in Neuroendocrine Tumors: Dr Jane Reeve Auckland DHB)...
Updates on PRRT in New Zealand
Unicorn Foundation NZ is continually working on behalf of its patient community to improve access to medicines and treatments in NZ. Recently the National Services Governance Group endorsed the PRRT application to proceed to service design, which is the first of...
INCA is a non-profit 501(c)3 organization incorporated in 2013.
